JERSEY CITY, N.J., Oct. 9, 2025 /PRNewswire/ — WallachBeth Capital LLC, a leading provider of capital markets and institutional execution services, announced today that bioAffinity Technologies, Inc. (NASDAQ: BIAF, BIAFW) a biotechnology company focused on the need […]
Tag: WallachBeth Capital LLC
WallachBeth Capital Announces Healthcare Triangle Warrant Inducement For Aggregate Gross Proceeds Of $755,000
JERSEY CITY, N.J., Oct. 3, 2025 /PRNewswire/ — WallachBeth Capital LLC, a leading provider of capital markets and institutional execution services, announced today that Healthcare Triangle, Inc. (Nasdaq: HCTI) (“HCTI” or the “Company”), a leader in […]
WallachBeth Capital Announces Closing of bioAffinity Technologies Public Offering for $4.8m
JERSEY CITY, N.J., Sept. 30, 2025 /PRNewswire/ — WallachBeth Capital LLC, a leading provider of capital markets and institutional execution services, announced today that bioAffinity Technologies, Inc. (NASDAQ: BIAF and BIAFW) a biotechnology company focused on […]
WallachBeth Capital Announces Pricing of bioAffinity Technologies Public Offering for $4.8m
JERSEY CITY, N.J., Sept. 29, 2025 /PRNewswire/ — WallachBeth Capital LLC, a leading provider of capital markets and institutional execution services, announced today that bioAffinity Technologies, Inc. (NASDAQ: BIAF and BIAFW) a biotechnology company focused on […]
WallachBeth Capital Announces Pricing of bioAffinity Technologies Public Offering for $4.8m
JERSEY CITY, N.J., Sept. 29, 2025 /PRNewswire/ — WallachBeth Capital LLC, a leading provider of capital markets and institutional execution services, announced today that bioAffinity Technologies, Inc. (NASDAQ: BIAF and BIAFW) a biotechnology company focused on […]